Role of taurine in the pathogenesis of obesity

Molecular Nutrition and Food Research

Volumn 59, Issue 7, 2015, Pages 1353-1363

  Murakami, Shigeru ^a  

^a FUKUI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Adipocyte; Bile acids; Obesity; Taurine

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; ANTIOBESITY AGENT; BILE ACID; TAURINE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; BLOOD; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; HUMAN; LIPID METABOLISM; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; BILE ACIDS AND SALTS; DISEASE MODELS, ANIMAL; HUMANS; LIPID METABOLISM; OBESITY; TAURINE;

EID: 84934436934     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500067     Document Type: Review

References (112)

1. Ouchi, N., Parker, J. L., Lugus, J. J., Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11, 85-97.
2. Gimeno, R. E., Klaman, L. D., Adipose tissue as an active endocrine organ: recent advances. Curr. Opin. Pharmacol. 2005, 5, 122-128.
3. Galic, S., Oakhill, J. S., Steinberg, G. R., Adipose tissue as an endocrine organ. Mol. Cell Endocrinol. 2010, 316, 129-139.
4. Ahima, R. S., Central actions of adipocyte hormones. Trends Endocrinol. Metab. 2005, 16, 307-313.
5. Trayhurn, P., Wood, I. S., Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 2004, 92, 347-355.
6. Tilg, H., Moschen, A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 2006, 6, 772-783.
7. Jacobsen, J. G., Smith, L. H., Biochemistry and physiology of taurine and taurine derivatives. Physiol. Rev. 1968, 48, 424-511.
8. Wright, C. E., Tallan, H. H., Lin, Y. Y., Gaull, G. E., Taurine: biological update. Annu. Rev. Biochem. 1986, 55, 427-453.
9. Kendler, B. S., Taurine: an overview of its role in preventive medicine. Prev. Med. 1989, 18, 79-100.
10. Huxtable, R. J., Physiological actions of taurine. Physiol. Rev. 1992, 72, 101-163.
11. Sturman, J. A., Taurine in development. Physiol. Rev. 1993, 73, 119-147.
12. Ide, T., Kushiro, M., Takahashi, Y., Shinohara, K., et al., mRNA expression of enzymes involved in taurine biosynthesis in rat adipose tissues. Metabolism 2002, 51, 1191-1197.
13. Tsuboyama-Kasaoka, N., Shozawa, C., Sano, K., Kamei, Y. et al., Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 2006, 147, 3276-3284.
14. Ueki, I., Stipanuk, M. H., 3T3-L1 adipocytes and rat adipose tissue have a high capacity for taurine synthesis by the cysteine dioxygenase/cysteinesulfinate decarboxylase and cysteamine dioxygenase pathways. J. Nutr. 2009, 139, 207-214.
15. Rosa, F. T., Freitas, E. C., Deminice, R., Jordão, A. A. et al., Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study. Eur. J. Nutr. 2014 53, 823-830.
16. Merheb, M., Daher, R. T., Nasrallah, M., Sabra, R. et al., Taurine intestinal absorption and renal excretion test in diabetic patients: a pilot study. Diabetes Care 2007, 30, 2652-2654.
17. Yamori, Y., Liu, L., Ikeda, K., Miura, A. et al., Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res. 2001, 24, 453-457
18. Yamori, Y., Taguchi, T., Mori, H., Mori, M., Low cardiovascular risks in the middle aged males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world. J. Biomed. Sci. 2010, 1(17 Suppl), S21.
19. Sagara, M., Murakami, S., Mizushima, S., Liu, L. et al., Taurine in 24-hour urine is inversely related to cardiovascular risks in middle aged subjects of 50 populations in the world. Adv. Exp. Med. Biol. 2015, in press.
20. Lin, S., Hirai, S., Yamaguchi, Y., Goto, T. et al., Taurine improves obesity-induced inflammatory responses and modulates the unbalanced phenotype of adipose tissue macrophages. Mol. Nutr. Food Res. 2013, 57, 2155-2165.
21. Weiss, S. J., Klein, R., Slivka, A., Wei, M., Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J. Clin. Invest. 1982, 70, 598-607.
22. Sethi, J. K., Vidal-Puig, A. J., Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J. Lipid Res. 2007, 48, 1253-1262.
23. Guilherme, A., Virbasius, J. V., Puri, V., Czech, M. P., Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 2008, 9, 367-377.
24. Chesney, R. W., Taurine: its biological role and clinical implications. Adv. Pediatr. 1985, 32, 1-42.
25. Takasaki, M., Satsu, H., Shimizu, M., Physiological significance of the taurine transporter and taurine biosynthetic enzymes in 3T3-L1 adipocytes. Biofactors 2004, 21, 419-421.
26. Lee, M. Y., Cheong, S. H., Chang, K. J., Choi, M. J. et al., Effect of the obesity index on plasma taurine levels in Korean female adolescents. Adv. Exp. Med. Biol. 2003, 526, 285-290.
27. Franconi, F., Bennardini, F., Mattana, A., Miceli, M. et al., Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am. J. Clin. Nutr. 1995, 61, 1115-1119.
28. Fujihira, E., Takahashi, H., Nakazawa, M., Effect of long-term feeding of taurine in hereditary hyperglycemic obese mice. Chem. Pharm. Bull. 1970, 18, 1636-1642.
29. Batista, T. M., Ribeiro, R. A., da Silva, P. M., Camargo, R. et al., Taurine supplementation improves liver glucose control in normal protein and malnourished mice fed a high-fat diet. Mol. Nutr. Food Res. 2013, 57, 423-434.
30. Nardelli, T. R., Ribeiro, R. A., Balbo, S. L., Vanzela, E. C. et al., Taurine prevents fat deposition and ameliorates plasma lipid profile in monosodium glutamate-obese rats. Amino Acids 2011, 41, 901-908.
31. Cao, P. J., Jin, Y. J., Li, M. E., Zhou, R. et al., PGC-1α may associated with the anti-obesity effect of taurine on rats induced by arcuate nucleus lesion. Nutr. Neurosci. 2014. doi.org/10.1179/1476830514Y.0000000153
32. Nakaya, Y., Minami, A., Harada, N., Sakamoto, S. et al., Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am. J. Clin. Nutr. 2000, 71, 54-58.
33. Mikami, N., Hosokawa, M., Miyashita, K., Dietary combination of fish oil and taurine decreases fat accumulation and ameliorates blood glucose levels in type 2 diabetic/obese KK-A(y) mice. J. Food Sci. 2012, 77, H114-H120.
34. Liaset, B., Madsen, L., Hao, Q., Criales G. et al., Fish protein hydrolysate elevates plasma bile acids and reduces visceral adipose tissue mass in rats. Biochim. Biophys. Acta. 2009, 1791, 254-262.
35. Tastesen, H. S., Keenan, A. H., Madsen, L., Kristiansen, K. et al., Scallop protein with endogenous high taurine and glycine content prevents high-fat, high-sucrose-induced obesity and improves plasma lipid profile in male C57BL/6J mice. Amino Acids 2014, 46, 1659-1671.
36. Kim, H. M., Do, C. H., Lee, D. H. et al., Characterization of taurine as anti-obesity agent in C. elegans. J. Biomed. Sci. 2010, 1(17 Suppl), S33.
37. Zhang, M., Bi, L. F., Fang, J. H., Su, X. L. et al., Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 2004, 26, 267-271.
38. Schuller-Levis, G. B., Park, E., Taurine and its chloramine: modulators of immunity. Neurochem. Res. 2004, 29, 117-126.
39. Kim, K. S., Ji, H. I., Chung, H., Kim, C. et al., Taurine chloramine modulates the expression of adipokines through inhibition of the STAT-3 signaling pathway in differentiated human adipocytes. Amino Acids 2013, 45, 1415-1422.
40. Lumeng, C. N., Saltiel, A. R., Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 2011, 121, 2111-2117.
41. Derosa, G., Fogari, E., D'Angelo, A., Bianchi, L. et al., Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation 2013, 36, 914-920.
42. Bouloumié, A., Curat, C. A., Sengenès, C., Lolmède, K. et al., Role of macrophage tissue infiltration in metabolic diseases. Curr. Opin. Clin. Nutr. Metab. Care 2005, 8, 347-354.
43. Chawla, A., Nguyen, K. D., Goh, Y. P., Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 2011, 11, 738-749.
44. Chinetti-Gbaguidi, G., Staels, B., Macrophage polarization in metabolic disorders: functions and regulation. Curr. Opin. Lipidol. 2011, 22, 365-372.
45. Gladine, C., Zmojdzian, M., Joumard-Cubizolles, L., Verny, M. A. et al., The omega-3 fatty acid docosahexaenoic acid favorably modulates the inflammatory pathways and macrophage polarization within aorta of LDLR(-/-) mice. Genes Nutr. 2014, 9, 424.
46. Feng, L., Song, P., Zhou, H., Li, A. et al., Pentamethoxyflavanone regulates macrophage polarization and ameliorates sepsis in mice. Biochem. Pharmacol. 2014, 89, 109-118.
47. Park, E., Quinn, M. R., Wright, C. E., Schuller-Levis, G., Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J. Leukoc. Biol. 1993, 54, 119-124.
48. Marcinkiewicz, J., Grabowska, A., Bereta, J., Stelmaszynska, T., Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J. Leukoc. Biol. 1995, 58, 667-674.
49. Marcinkiewicz, J., Grabowska, A., Bereta, J., Bryniarski, K. et al., Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 1998, 40, 27-38.
50. Marcinkiewicz, J., Kontny, E., Taurine and inflammatory diseases. Amino Acids 2014, 46, 7-20.
51. Fukuda, K., Hirai, Y., Yoshida, H., Nakajima, T. et al., Free amino acid content of lymphocytes nd granulocytes compared. Clin. Chem. 1982, 28, 1758-1761.
52. Kanayama, A., Inoue, J., Sugita-Konishi, Y., Shimizu, M. et al., Oxidation of IκBα at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-κB activation. J. Biol. Chem. 2002, 277, 24049-24056.
53. Muz, B., Kontny, E., Marcinkiewicz, J., Maśliński, W., Heme oxygenase-1 participates in the anti-inflammatory activity of taurine chloramine. Amino Acids 2008, 35, 397-402.
54. Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y. et al., Adiponectin: a key adipocytokine in metabolic syndrome. Clin. Sci. 2006, 110, 267-278.
55. Stefan, N., Stumvoll, M., Adiponectin-its role in metabolism and beyond. Horm. Metab. Res. 2002, 34, 469-474.
56. You, J. S., Zhao, X., Kim, S. H., Chang, K. J. et al., Positive correlation between serum taurine and adiponectin levels in high-fat diet-induced obesity rats. Adv. Exp. Med. Biol. 2013, 776, 105-111.
57. Chen, S. W., Chen, Y. X., Shi, J., Lin, Y. et al., The restorative effect of taurine on experimental nonalcoholic steatohepatitis. Dig. Dis. Sci. 2006, 51, 2225-2234.
58. Chen, X., Sebastian, B. M., Tang, H., McMullen, M. M. et al., Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats. Hepatology 2009, 49, 1554-1562.
59. Moreira P. I., Zhu, X., Wang, X., Lee, H. G. et al., Mitochondria: a therapeutic target in neurodegeneration. Biochim. Biophys. Acta. 2010, 1802, 212-220.
60. Rosca, M. G., Hoppel, C. L., Mitochondria in heart failure. Cardiovasc. Res. 2010, 88, 40-50.
61. Szendroedi, J., Phielix, E., Roden, M., The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 2011, 8, 92-103.
62. McInnes, J., Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress. Nutr. Metab. 2013, 10, 63.
63. Bournat, J. C., Brown, C. W., Mitochondrial dysfunction in obesity. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17, 446-452.
64. Talior, I., Yarkoni, M., Bashan, N., Eldar-Finkelman, H., Increased glucose uptake promotes oxidative stress and PKC-δ activation in adipocytes of obese, insulin-resistant mice. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E295-E302.
65. Degasperi, G. R., Denis, R. G., Morari, J., Solon, C. et al., Reactive oxygen species production is increased in the peripheral blood monocytes of obese patients. Metabolism 2009, 58, 1087-1095.
66. Vincent, H. K., Taylor, A. G., Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int. J. Obes. 2006, 30, 400-418.
67. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M. et al., Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114, 1752-1761.
68. Umeda, N., Suzuki, T., Yukawa, M., Ohya, Y. et al., Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs. Implications for the molecular pathogenesis of human mitochondrial diseases. J. Biol. Chem. 2005, 280, 1613-1624.
69. Suzuki, T., Suzuki, T., Wada, T., Saigo, K. et al., Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J. 2002, 21, 6581-6589.
70. Kirino, Y., Yasukawa, T., Ohta, S., Akira, S. et al., Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc. Natl. Acad. Sci. USA 2004, 101, 15070-15075.
71. Rikimaru, M., Ohsawa, Y., Wolf, A. M., Nishimaki, K. et al., Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS. Intern. Med. 2012, 51, 3351-3357.
72. Schaffer, S. W., Jong, C. J., Ito, T., Azuma, J., Role of taurine in the pathologies of MELAS and MERRF. Amino Acids 2014, 46, 47-56.
73. Sun, M., Gu, Y., Zhao, Y., Xu, C., Protective functions of taurine against experimental stroke through depressing mitochondria-mediated cell death in rats. Amino Acids 2011, 40, 1419-1429.
74. Chang, L., Xu, J., Yu, F., Zhao, J. et al., Taurine protected myocardial mitochondria injury induced by hyperhomocysteinemia in rats. Amino Acids 2004, 27, 37-48.
75. Roy, A., Manna, P., Sil, P. C., Prophylactic role of taurine on arsenic mediated oxidative renal dysfunction via MAPKs/ NF-κB and mitochondria dependent pathways. Free Radic. Res. 2009, 43, 995-1007.
76. Das, J., Ghosh, J., Manna, P., Sil, P. C., Protective role of taurine against arsenic-induced mitochondria-dependent hepatic apoptosis via the inhibition of PKCδ-JNK pathway. PLoS One 2010, 5, e12602.
77. Chen, K., Zhang, Q., Wang, J., Liu, F. et al., Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Brain Res. 2009, 1279, 131-138.
78. Lee, Y. Y., Lee, H. J., Lee, S. S., Koh, J. S. et al., Taurine supplementation restored the changes in pancreatic islet mitochondria in the fetal protein-malnourished rat. Br. J. Nutr. 2011, 106, 1198-1206.
79. Chang, L., Xu, J. X., Zhao, J., Pang, Y. Z. et al., Taurine antagonized oxidative stress injury induced by homocysteine in rat vascular smooth muscle cells. Acta Pharmacol. Sin. 2004, 25, 341-346.
80. El Idrissi, A., Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids 2008, 34, 321-328.
81. Jong, C. J., Azuma, J., Schaffer, S., Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids 2012, 42, 2223-2232.
82. Hansen, S. H., Andersen, M. L., Cornett, C., Gradinaru, R. et al., A role for taurine in mitochondrial function. J. Biomed. Sci. 2010, 1(17 Suppl), S23.
83. Murakami, S., Yamagishi, I., Asami, Y., Ohta, Y. et al., Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats. Pharmacology 1996, 52, 303-313.
84. Yokogoshi, H., Mochizuki, H., Nanami, K., Hida, Y. et al., Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J. Nutr. 1999, 129, 1705-1712.
85. Murakami, S., Kondo-Ohta, Y., Tomisawa, K., Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci. 1999, 64, 83-91.
86. Murakami, S., Kondo, Y., Toda, Y., Kitajima, H. et al., Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci. 2002, 70, 2355-2366.
87. Murakami, S., Sakurai, T., Tomoike, H., Sakono, M. et al., Prevention of hypercholesterolemia and atherosclerosis in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail by taurine supplementation. Amino Acids 2010, 38, 271-278.
88. Yamamoto, K., Yoshitama, A., Sakono, M., Nasu, T. et al., Dietary taurine decreases hepatic secretion of cholesterol ester in rats fed a high-cholesterol diet. Pharmacology 2000, 60, 27-33.
89. Yanagita, T., Han, S. Y., Hu, Y., Nagao, K. et al., Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells. Lipids Health Dis. 2008, 7, 38.
90. Chang, Y. Y., Chou, C. H., Chiu, C. H., Yang, K. T. et al., Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol dietary habit. J. Agric. Food Chem. 2011, 59, 450-457.
91. Gentile, C. L., Nivala, A. M., Gonzales, J. C., Pfaffenbach, K. T., Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301, R1710-R1722.
92. Fukuda, N., Yoshitama, A., Sugita, S., Fujita, M. et al., Dietary taurine reduces hepatic secretion of cholesteryl ester and enhances fatty acid oxidation in rats fed a high-cholesterol diet. J. Nutr. Sci. Vitaminol. 2011, 57, 144-149.
93. 2 generation and activates Pka and lipolysis. Amino Acids 2012, 42, 1927-1935.
94. Puigserver, P., Wu, Z., Park, C. W., Graves, R. et al., A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92, 829-839.
95. Kumari, N., Prentice, H., Wu, J. Y., Taurine and its neuroprotective role. Adv. Exp. Med. Biol. 2013, 775, 19-27.
96. Albrecht, J., Schousboe, A., Taurine interaction with neurotransmitter receptors in the CNS: an update. Neurochem. Res. 2005, 30, 1615-1621.
97. Solon, C. S., Franci, D., Ignacio-Souza, L. M., Romanatto, T. et al., Taurine enhances the anorexigenic effects of insulin in the hypothalamus of rats. Amino Acids 2012, 42, 2403-2410.
98. Pliquett, R. U., Führer, D., Falk, S., Zysset, S. et al., The effects of insulin on the central nervous system-focus on appetite regulation. Horm. Metab. Res. 2006, 38, 442-446.
99. Abizaid, A., Horvath, T. L., Brain circuits regulating energy homeostasis. Regul. Pept. 2008, 149, 3-10.
100. Air, E. L., Benoit, S. C., Clegg, D. J., Seeley, R. J. et al., Insulin and leptin combine additively to reduce food intake and body weight in rats. Endocrinology 2002, 143, 2449-2452.
101. Menéndez, J. A., Atrens, D. M., Insulin and the paraventricular hypothalamus: modulation of energy balance. Brain Res. 1991, 555, 193-201.
102. Camargo, R. L., Batista, T. M., Ribeiro, R. A., Velloso, L. A. et al., Effects of taurine supplementation upon food intake and central insulin signaling in malnourished mice fed on a high-fat diet. Adv. Exp. Med. Biol. 2013, 776, 93-103.
103. Murakami, T., Furuse, M., The impact of taurine- and beta-alanine-supplemented diets on behavioral and neurochemical parameters in mice: antidepressant versus anxiolytic-like effects. Amino Acids 2010, 39, 427-434.
104. Uhe, A. M., Collier, G. R., O'Dea, K., A comparison of the effects of beef, chicken and fish protein on satiety and amino acid profiles in lean male subjects. J. Nutr. 1992, 122, 467-472.
105. Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S. et al., Bile acids as regulatory molecules. J. Lipid Res. 2009, 50, 1509-1520.
106. Sharma, R., Long, A., Gilmer, J. F., Advances in bile acid medicinal chemistry. Curr. Med. Chem. 2011, 18, 4029-4052.
107. Lefebvre, P., Cariou, B., Lien, F., Kuipers, F. et al., Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 2009, 89, 147-191.
108. Duboc, H., Taché, Y., Hofmann, A. F. et al., The bile acid TGR5 membrane receptor: from basic research to clinical application. Dig. Liver Dis. 2014, 46, 302-312.
109. Pols, T. W., Noriega, L. G., Nomura, M., Auwerx, J. et al., The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J. Hepatol. 2011, 54, 1263-1272.
110. Kawamata, Y., Fujii, R., Hosoya, M., Harada, M. et al., A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 2003, 278, 9435-9440.
111. Zhong, M., TGR5 as a therapeutic target for treating obesity. Curr. Top Med. Chem. 2010, 10, 386-396.
112. Kibe, A., Wake, C., Kuramoto, T., Hoshita, T., Effect of dietary taurine on bile acid metabolism in guinea pigs. Lipids 1980, 15, 224-229.